Cargando…
Outcomes and Risk Factors for Mortality among Patients Treated with Carbapenems for Klebsiella spp. Bacteremia
BACKGROUND: Extensive dissemination of carbapenemase-producing Enterobacteriaceae has led to increased resistance among Klebsiella species. Carbapenems are used as a last resort against resistant pathogens, but carbapenemase production can lead to therapy failure. Identification of risk factors for...
Autores principales: | Biehle, Lauren R., Cottreau, Jessica M., Thompson, David J., Filipek, Rachel L., O’Donnell, J. Nicholas, Lasco, Todd M., Mahoney, Monica V., Hirsch, Elizabeth B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4664260/ https://www.ncbi.nlm.nih.gov/pubmed/26618357 http://dx.doi.org/10.1371/journal.pone.0143845 |
Ejemplares similares
-
Mortality Impact of CLSI Carbapenem Breakpoint Changes in Enterobacteriaceae Bloodstream Infections: a Patient-level Analysis of Published Data
por: O’Donnell, J Nicholas, et al.
Publicado: (2017) -
Successful treatment of hypervirulent Klebsiella pneumoniae bacteremia with combination carbapenem and rifampicin
por: Lin, Yong-Chun, et al.
Publicado: (2021) -
Multicenter Genomic Analysis of Carbapenem-Resistant Klebsiella pneumoniae from Bacteremia in China
por: Cienfuegos-Gallet, Astrid V., et al.
Publicado: (2022) -
The evolutionary mechanism of non-carbapenemase carbapenem-resistant phenotypes in Klebsiella spp
por: Rosas, Natalia C, et al.
Publicado: (2023) -
Carbapenem-resistant Klebsiella pneumoniae in high-risk haematological patients: factors favouring spread, risk factors and outcome of carbapenem-resistant Klebsiella pneumoniae bacteremias
por: Micozzi, Alessandra, et al.
Publicado: (2017)